Procter & Gamble (PG) to Axe Up to 6,000 Office Jobs Worldwide
Celgene (CELG) Picks Up San Francisco Biotech Quanticel Pharmaceuticals in $485 Million Deal
Resverlogix Corporation (RVX.TO), Shenzhen Hepalink Pharma Strike Deal Worth $450 Million+
Teva (TEVA) Pays $23.2 Million to Dump OncoGenex Pharmaceuticals Inc. (OGXI) Drug
EXCLUSIVE: Jounce CEO Says Funding Aims for Trials Next Year, Will Hire 10
Celgene (CELG) Slaps Down $450 Million Upfront for AstraZeneca PLC (AZN)'s Prized Immunotherapy Blood Cancer Drug
Seattle Genetics (SGEN) to Hire 100 Employees in Anticipation of Company Growth
Innate Pharma (IPH.PA ) Strikes Cancer Pact Worth $1.275 Billion With Pharma Giant AstraZeneca PLC (AZN)
As Mylan (MYL), Perrigo (PRGO) and Teva (TEVA) Maneuver For Acquisitions, 30,000 Jobs Hang in the Balance
Aerie (AERI) Freefalls Aftermarket as Rhopressa Fails Phase III Study
Texas Psychiatrists Accused of Accepting Bribes from AstraZeneca PLC (AZN) to Manipulate State Formulary
Merck & Co. (MRK) Poised To Enter Oral HCV Market Dominated by Gilead (GILD) and AbbVie (ABBV)
Could Google (GOOG) Be a Buyer for Former Merck & Co. (MRK) HQ?
Small Biotech Clovis Oncology (CLVS)'s Breakthrough Drugs May Catch the Eye of Pfizer (PFE), Roche (RHHBY)
Jounce Infused With $56 Million to Develop Cancer Immunotherapy Programs
Amgen (AMGN) Boasts 51% Rise in Profit, Abandons Phase II Brodalumb Study, but Pushes Biosimilars
Gilead (GILD) Offers Free Drugs in Georgia in Hep C Eradication Experiment
Almirall Slashes 59 R&D Jobs as Restructuring Continues
See All News >
Could Google (GOOG) Be a Buyer for Former Merck & Co. (MRK) HQ?
Small Biotech Clovis Oncology (CLVS)'s Breakthrough Drugs May Catch the Eye of Pfizer (PFE), Roche (RHHBY)
Jounce Infused With $56 Million to Develop Cancer Immunotherapy Programs
Amgen (AMGN) Boasts 51% Rise in Profit, Abandons Phase II Brodalumb Study, but Pushes Biosimilars
Gilead (GILD) Offers Free Drugs in Georgia in Hep C Eradication Experiment
How Abbott (ABT) is Reaping Rewards From Teva (TEVA)'s Bid for Mylan (MYL)
Novartis AG (NVS) Hunts for Bolt-On Acquisitions Worth $2 Billion to $5 Billion
Rumors Swirl Pfizer (PFE) Will Bid for AstraZeneca PLC (AZN) Again
Why Ariad (ARIA) Could Be Worth $3 Billion to a Big Drugmaker
Bayer HealthCare (BAY) to Shutter Kansas Plant, 130 Jobs Terminated
Buy Vertex (VRTX) Now for $45B Or Risk It All, Analyst Tells Gilead (GILD)
Pfizer (PFE)'s New Leukemia Drug Meets Hematologic Remission Endpoint in Phase III Study
Novartis AG (NVS) Taps Cancer Guru to Head Boston R&D Group That Specializes in Immuno-Oncology
Stealth SoCal Startup Metacrine Eyes $33 Million and Talent-Cash From Seragon Alums?
Biogen (BIIB) Loaded With Talented Women Execs, as CEO Pushes to Diversify Boardroom
CAR-T Cell Companies Juno Therapeutics (JUNO), Kite Pharma (KITE), and ZIOPHARM, Inc. Get Stock Jitters on Disappointing Novartis AG (NVS) Trial News
Roche (RHHBY) Still Bullish on Alzheimer’s Research After Biogen (BIIB)’s Successful Clinical Trial
New York VC Firm Oberland Capital Secures $425 Million for Life Sciences, Medtech
See All News >
//-->